Android app Apple app link

Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS) (APOPW) Financials

NASDAQ Currency in USD Disclaimer

$0.09

north_east NA Past Year
Day's range
$0.05
Day's range
$0.09

APOPW Income statement / Annual

Last year (2024), Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS)'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS)'s net income was -$8.96 B. See Cellect Biotechnology Ltd. Warrants to Purchase ADR (1 WT and $7.50 to purchase 1 ADS),s key income statements, including revenue, expenses, profit, and income.

Period FY-2024
Period Ended 12/31/2024
Operating Revenue $0.00
Cost of Revenue $0.00
Gross Profit $0.00
Gross Profit Ratio 0
Research and Development Expenses $3.60 B
General & Administrative Expenses $5.93 B
Selling & Marketing Expenses $0.00
Selling, General & Administrative Expenses $5.93 B
Other Expenses $0.00
Operating Expenses $9.53 B
Cost And Expenses $0.00
Interest Income $0.00
Interest Expense $0.00
Depreciation & Amortization $0.00
EBITDA $0.00
EBITDA Ratio 0
Operating Income Ratio 0
Total Other Income/Expenses Net $0.00
Income Before Tax -$8.96 B
Income Before Tax Ratio 0
Income Tax Expense $0.00
Net Income -$8.96 B
Net Income Ratio 0
EPS -1911.5
EPS Diluted -1911.5
Weighted Average Shares Out $4.69 M
Weighted Average Shares Out Diluted $4.69 M
Link

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.